RS63736B1 - Rastvor bortezomiba spreman za upotrebu - Google Patents

Rastvor bortezomiba spreman za upotrebu

Info

Publication number
RS63736B1
RS63736B1 RS20221025A RSP20221025A RS63736B1 RS 63736 B1 RS63736 B1 RS 63736B1 RS 20221025 A RS20221025 A RS 20221025A RS P20221025 A RSP20221025 A RS P20221025A RS 63736 B1 RS63736 B1 RS 63736B1
Authority
RS
Serbia
Prior art keywords
bortezomib
ready
use solution
solution
Prior art date
Application number
RS20221025A
Other languages
English (en)
Inventor
Edgar Schridde
Original Assignee
Stada Arzneimittel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53719596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS63736(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stada Arzneimittel Ag filed Critical Stada Arzneimittel Ag
Publication of RS63736B1 publication Critical patent/RS63736B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
RS20221025A 2015-07-22 2016-07-21 Rastvor bortezomiba spreman za upotrebu RS63736B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15002163.2A EP3120836A1 (de) 2015-07-22 2015-07-22 Gebrauchsfertige bortezomib-lösung
EP16744351.4A EP3324937B1 (de) 2015-07-22 2016-07-21 Gebrauchsfertige bortezomib-lösung
PCT/EP2016/067413 WO2017013208A1 (de) 2015-07-22 2016-07-21 Gebrauchsfertige bortezomib-lösung

Publications (1)

Publication Number Publication Date
RS63736B1 true RS63736B1 (sr) 2022-12-30

Family

ID=53719596

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20221025A RS63736B1 (sr) 2015-07-22 2016-07-21 Rastvor bortezomiba spreman za upotrebu

Country Status (8)

Country Link
EP (3) EP3120836A1 (sr)
KR (1) KR20180033247A (sr)
DE (2) DE202016008851U1 (sr)
DK (1) DK3324937T3 (sr)
ES (1) ES2895772T3 (sr)
PT (1) PT3324937T (sr)
RS (1) RS63736B1 (sr)
WO (1) WO2017013208A1 (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3120837A1 (de) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Verfahren zur herstellung einer bortezomibester-lösung
EP3120836A1 (de) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Gebrauchsfertige bortezomib-lösung
WO2020144607A1 (en) * 2019-01-11 2020-07-16 Intas Pharmaceuticals Ltd. A process for preparation of a stable pharmaceutical composition of bortezomib
US11986486B2 (en) 2020-11-02 2024-05-21 Spes Pharmaceuticals Inc. Aqueous compositions of bortezomib
US20230104074A1 (en) 2021-09-24 2023-04-06 MAIA Pharmaceuticals, Inc. Bortezomib compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913386A (en) 1956-03-21 1959-11-17 Jr Leland C Clark Electrochemical device for chemical analysis
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
US6274169B1 (en) 1999-08-02 2001-08-14 Abbott Laboratories Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
PT1355910E (pt) 2001-01-25 2011-03-24 Us Of America Represented By The Secretary Dept Of Health And Human Services Formulação de compostos do ácido borónico
EA027346B1 (ru) 2008-06-17 2017-07-31 Милленниум Фармасьютикалз, Инк. Соединения боронатного эфира и его фармацевтические составы
US9061037B2 (en) 2010-03-18 2015-06-23 Innopharma, Inc. Stable bortezomib formulations
KR101069128B1 (ko) 2011-03-10 2011-09-30 건일제약 주식회사 페메트렉시드 또는 그의 염을 포함하는 항산화제-비함유 주사용 용액 형태의 약학적 제제의 제조방법
AU2013227219A1 (en) * 2012-03-02 2014-10-23 Dr. Reddy's Laboratories Limited Pharmaceutical compositions comprising boronic acid compounds
CA2784240C (en) * 2012-03-27 2014-07-08 Innopharma, Inc. Stable bortezomib formulations
EA021179B1 (ru) 2012-06-15 2015-04-30 Ощество С Ограниченной Ответственностью "Тева" Лиофилизат соединения бороновой кислоты
WO2015025000A1 (en) * 2013-08-23 2015-02-26 Synthon B.V. Pharmaceutical compositions comprising bortezomib
EP3120836A1 (de) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Gebrauchsfertige bortezomib-lösung

Also Published As

Publication number Publication date
PT3324937T (pt) 2022-10-28
DE202016009131U1 (de) 2022-08-15
ES2895772T3 (es) 2022-11-17
EP3324937B1 (de) 2022-08-17
EP3120836A1 (de) 2017-01-25
EP3324937A1 (de) 2018-05-30
DK3324937T3 (da) 2022-11-14
EP4101441A1 (de) 2022-12-14
ES2895772T1 (es) 2022-02-22
KR20180033247A (ko) 2018-04-02
WO2017013208A1 (de) 2017-01-26
DE202016008851U1 (de) 2020-03-09

Similar Documents

Publication Publication Date Title
HK1245266A1 (zh) 作為usp30抑制劑的1-氰基吡咯烷化合物
ZA201705060B (en) Use of picolinamides as fungicides
HK1258062A1 (zh) 給予惡拉戈利的方法
SG11201706729SA (en) Derivatives of sobetirome
GB201419865D0 (en) Solution
PL3470151T3 (pl) Formowanie elementów akumulatora
IL285882A (en) Medicinal uses for l–4–chlorokynurenine
ZA201606075B (en) Pharmaceutical compositions of sitagliptin
PT3334734T (pt) Forma c de avibactam sódico
RS63736B1 (sr) Rastvor bortezomiba spreman za upotrebu
PL3224338T3 (pl) Wodny roztwór zawierający połączenie środków kompleksujących
GB201418395D0 (en) Cyclo-depolymerisation of polybutadiene
ZA201700518B (en) Use of active compound compositions
IL255498A (en) Treatment of pruritus
SG11201702334SA (en) External preparation composition containing s-flurbiprofen
IL249130B (en) Preparation of piperidine-4-carbothioamide
GB2550525B (en) Forming of battery components
HUP1500506A2 (en) Salts of palbociclib
GB2544782B (en) Solution
GB2531867B (en) Multiplication of three numbers
GB201512635D0 (en) Uses of therapeutic compounds
GB201505574D0 (en) Improvements to OIS
GB201417343D0 (en) Prodrugs of bortezomib
GB201414132D0 (en) Prodrugs of bortezomib